India's Piramal Pharma up after FDA closes inspection of US unit

Piramal Pharma (Mumbai)

09/11/2023 06:34

** Shares of Piramal Pharma  PIRM.NS  up as much as 4.2% to
120.4 rupees
    ** Stock on track for a fourth consecutive session of gains,
if trend holds
    ** Pharmaceuticals firm said the US Food and Drug
Administration (US FDA) has issued an Establishment Inspection
Report (EIR) for its manufacturing facility at Bethlehem in the
US, after closing an inspection 
    ** Stock last up 3.9%, boosting YTD gains to 7.3%

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))